Anthropic filed an updated prospectus with the SEC on November 17. It plans to sell 825 million Class A shares at $70 to $78 each and has been approved to list on Nasdaq as ANT. The shares don't trade yet. Anthropic says any third party selling its stock to the public, including through tokens, is likely offering something that may have no value.

Key facts

  • Who: Anthropic, PBC, the AI company that makes Claude, and its underwriters led by Goldman Sachs and Morgan Stanley
  • What: Amended Form S-1: 825 million Class A shares, estimated $70 to $78 each, Nasdaq symbol ANT
  • When: Filed November 17, 2026; no trading date is set in the filing
  • Warning: Anthropic says unapproved sales of its stock are void and calls tokenized offers likely worthless
  • Source: Anthropic amended Form S-1, SEC

Connection: DeFi Market Journal pays to use Claude, Anthropic's AI assistant, in its work. Anthropic had no say in this story. Nothing here is a recommendation to buy.

The Anthropic IPO has a price range now. In a filing dated November 17, the company says it expects to sell shares at "between $70.00 and $78.00," according to its amended prospectus. It has "been approved to list" on the Nasdaq Global Select Market under the symbol ANT.

That is a step, not the finish. The shares still don't trade, and the filing gives no date. Until they do, offers to get you in early keep landing in inboxes and chat apps. We explained how those pitches work when Anthropic first filed in October.

What the new filing says

Anthropic plans to sell 825 million Class A shares. It is selling about 801 million itself, and existing holders are selling about 24 million more. The underwriters, led by Goldman Sachs and Morgan Stanley, can buy up to 123.75 million extra shares.

The filing replaces terms the company pulled back last week. Anthropic told banks that earlier pricing figures were incorrect and that an updated filing would follow, City AM reported, citing Reuters. The filing also says a minority of shares may go to individual investors.

What Anthropic says about early offers

Anthropic keeps a public warning about this. Any sale of its stock that its board hasn't approved "is void and will not be recognized on our books and records," the page says. It does not allow special purpose vehicles, the pooled funds that often sell "indirect access," to buy its shares.

For crypto readers, one line stands out. Anyone selling its shares to the public through "direct sales, 'forward contracts,' tokenized securities, or other mechanisms" is likely offering an investment "that may have no value," Anthropic says. A token with Anthropic's name on it is not a share of ANT.

The red flags, in Anthropic's own list

  • Someone contacts you first by email, social media or a messaging app offering Anthropic shares.
  • The offer claims "exclusive" or "limited-time" access.
  • You're asked to pay in crypto, by wire, or in other hard-to-trace ways.
  • You're pushed to decide quickly.

What a real chance to buy looks like

IPO shares reach the public through the underwriters and the brokerages they work with. If you get an allocation offer, it should show up inside a brokerage account you already opened yourself, not in a DM. You can look up any broker on FINRA BrokerCheck.

Once ANT starts trading, any regular brokerage can place an order. Nobody can sell you that stock early through a wallet, a group chat or a token. If you already paid someone, our crypto recovery scams guide explains the second wave of offers that usually follows.

Sources: Anthropic, PBC, Amendment to Form S-1 Registration Statement, SEC EDGAR (dated November 17, 2026), Anthropic, Unauthorized Anthropic stock sales and investment scams, Claude Help Center (originally published February 11, 2026; updated June 29, 2026), City AM, Anthropic retracts $69bn IPO plans after sending inaccurate figures to banks (November 10, 2026).